Oncology News

Physically active patients with nonalcoholic fatty liver disease were more likely to achieve at least a 30% reduction in MRI-measured liver fat, according to research in The American Journal of Gastroenterology.

Patients with hepatocellular carcinoma carried a “significantly higher” cancer-related financial burden compared with those with cirrhosis, according to data published in Clinical Gastroenterology and Hepatology.

A machine learning model may aid the detection and classification of tertiary lymphoid structures associated with gastrointestinal cancers based on routine tissue slides, according to research in JAMA Network Open.

CMS has announced expanded coverage for specific colorectal cancer screening tests by lowering the minimum age to include individuals aged 45 years and older under Medicare Part B.

A greater percentage of colorectal cancer cases in the United States are being diagnosed at advanced stages, according to an American Cancer Society report.

Although colonoscopies performed later in the day correlated with a decreased adenoma detection rate, researchers reported that artificial intelligence systems may offset time-related decline in colonoscopy quality.

Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.

Rates of past-year screening for breast, cervical and prostate cancer in 2021 remained below prepandemic levels as millions of eligible Americans continued to forgo testing, according to a study published in Journal of Clinical Oncology.

The incidence of pancreatic cancer increased at a faster rate over time among women aged younger than 55 years compared with their male counterparts, according to research published in Gastroenterology.

A phase 3 trial of trilaciclib in combination FOLFOXIRI and bevacizumab for patients with metastatic colorectal cancer met its co-primary endpoints but will be terminated based on early efficacy data, according to the agent’s manufacturer.